Cargando…
Making the most of high‐dimensional cytometry data
High‐dimensional cytometry represents an exciting new era of immunology research, enabling the discovery of new cells and prediction of patient responses to therapy. A plethora of analysis and visualization tools and programs are now available for both new and experienced users; however, the transit...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453896/ https://www.ncbi.nlm.nih.gov/pubmed/33797774 http://dx.doi.org/10.1111/imcb.12456 |
_version_ | 1784570373355864064 |
---|---|
author | Marsh‐Wakefield, Felix MD Mitchell, Andrew J Norton, Samuel E Ashhurst, Thomas Myles Leman, Julia KH Roberts, Joanna M Harte, Jessica E McGuire, Helen M Kemp, Roslyn A |
author_facet | Marsh‐Wakefield, Felix MD Mitchell, Andrew J Norton, Samuel E Ashhurst, Thomas Myles Leman, Julia KH Roberts, Joanna M Harte, Jessica E McGuire, Helen M Kemp, Roslyn A |
author_sort | Marsh‐Wakefield, Felix MD |
collection | PubMed |
description | High‐dimensional cytometry represents an exciting new era of immunology research, enabling the discovery of new cells and prediction of patient responses to therapy. A plethora of analysis and visualization tools and programs are now available for both new and experienced users; however, the transition from low‐ to high‐dimensional cytometry requires a change in the way users think about experimental design and data analysis. Data from high‐dimensional cytometry experiments are often underutilized, because of both the size of the data and the number of possible combinations of markers, as well as to a lack of understanding of the processes required to generate meaningful data. In this article, we explain the concepts behind designing high‐dimensional cytometry experiments and provide considerations for new and experienced users to design and carry out high‐dimensional experiments to maximize quality data collection. |
format | Online Article Text |
id | pubmed-8453896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84538962021-09-27 Making the most of high‐dimensional cytometry data Marsh‐Wakefield, Felix MD Mitchell, Andrew J Norton, Samuel E Ashhurst, Thomas Myles Leman, Julia KH Roberts, Joanna M Harte, Jessica E McGuire, Helen M Kemp, Roslyn A Immunol Cell Biol Review High‐dimensional cytometry represents an exciting new era of immunology research, enabling the discovery of new cells and prediction of patient responses to therapy. A plethora of analysis and visualization tools and programs are now available for both new and experienced users; however, the transition from low‐ to high‐dimensional cytometry requires a change in the way users think about experimental design and data analysis. Data from high‐dimensional cytometry experiments are often underutilized, because of both the size of the data and the number of possible combinations of markers, as well as to a lack of understanding of the processes required to generate meaningful data. In this article, we explain the concepts behind designing high‐dimensional cytometry experiments and provide considerations for new and experienced users to design and carry out high‐dimensional experiments to maximize quality data collection. John Wiley and Sons Inc. 2021-05-04 2021-08 /pmc/articles/PMC8453896/ /pubmed/33797774 http://dx.doi.org/10.1111/imcb.12456 Text en © 2021 The Authors. Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Review Marsh‐Wakefield, Felix MD Mitchell, Andrew J Norton, Samuel E Ashhurst, Thomas Myles Leman, Julia KH Roberts, Joanna M Harte, Jessica E McGuire, Helen M Kemp, Roslyn A Making the most of high‐dimensional cytometry data |
title | Making the most of high‐dimensional cytometry data |
title_full | Making the most of high‐dimensional cytometry data |
title_fullStr | Making the most of high‐dimensional cytometry data |
title_full_unstemmed | Making the most of high‐dimensional cytometry data |
title_short | Making the most of high‐dimensional cytometry data |
title_sort | making the most of high‐dimensional cytometry data |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453896/ https://www.ncbi.nlm.nih.gov/pubmed/33797774 http://dx.doi.org/10.1111/imcb.12456 |
work_keys_str_mv | AT marshwakefieldfelixmd makingthemostofhighdimensionalcytometrydata AT mitchellandrewj makingthemostofhighdimensionalcytometrydata AT nortonsamuele makingthemostofhighdimensionalcytometrydata AT ashhurstthomasmyles makingthemostofhighdimensionalcytometrydata AT lemanjuliakh makingthemostofhighdimensionalcytometrydata AT robertsjoannam makingthemostofhighdimensionalcytometrydata AT hartejessicae makingthemostofhighdimensionalcytometrydata AT mcguirehelenm makingthemostofhighdimensionalcytometrydata AT kemproslyna makingthemostofhighdimensionalcytometrydata |